The AZGP1 gene helps your body release and use stored fat, especially when energy needs change. If it does not work as expected, your body may handle fat differently, which can influence weight, metabolism, and energy balance. This gene plays an important role in how tissues communicate about energy use. Researchers also study the AZGP1 gene in prostate and some other cancers because changes in its activity can be linked to how tumors behave.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly guide when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a closer look at this topic, you can find more in the LearnHub.
Overview
AZGP1Gene function
What if the gene works
The AZGP1 gene makes a protein found in blood and other body fluids that helps regulate fat breakdown and may support immune signaling.
Risk
What if the gene does not work
If the AZGP1 gene works less well, cells may make too little or altered zinc-α2-glycoprotein, a protein released into body fluids. Milder to more severe variants can reduce how well it folds, is secreted, or interacts with fats.
Treatment
What does that mean for your treatment
No AZGP1-specific treatment or drug choice approach is currently established for pathogenic or loss-of-function variants in the AZGP1 gene. The AZGP1 gene is being studied mainly as a biomarker in some cancers, kidney disease, and body weight changes, not as a guide for approved therapy.
Gene function
What if the gene works
Your body uses the AZGP1 gene to help manage how stored fat becomes usable fuel. It makes a protein that is released from cells and works as a signal in the spaces between tissues. This helps explain the AZGP1 gene’s function in body fat metabolism and everyday energy balance.
Inside fat tissue, the AZGP1 gene supports the release of stored fat when the body needs energy. Its protein helps shift fat from storage toward use as fuel.
By helping stored fat become available, this gene supports normal energy balance across the day. That includes quieter periods such as the hours between meals and during sleep.
The AZGP1 gene makes a protein that is released into body fluids, including blood. This lets the protein act as a signal between tissues rather than staying inside a single cell.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the AZGP1 gene can change how much AZGP1 protein a cell makes, how well it folds, and whether it is released normally. Milder changes may slightly reduce protein stability or interactions, while more severe variants, including changes that shorten the protein, can markedly lower or abolish secretion. This range helps explain how variants in the AZGP1 gene affect protein function at the cellular level.
How variants are linked to conditions
Current evidence does not yet show a broadly confirmed link between variants in the AZGP1 gene and one specific health condition, though research on how AZGP1 gene variants are linked to conditions is still evolving. Anyone with a confirmed AZGP1-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Gene variants are a normal part of human biology and are widely found in the general population. Most have no direct impact on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the AZGP1 gene itself. AZGP1 has been studied in body weight, metabolism, and some cancers, but personal risk is shaped by many genes, overall health, and everyday factors rather than this gene alone.
Inheritance of AZGP1 variants
There is not yet a broadly confirmed disease specific inheritance pattern for the AZGP1 gene, so how AZGP1 gene variants are inherited in a clinical sense is still being clarified as research develops. AZGP1 is located on chromosome 7, which is an autosome. That means you inherit one copy of the AZGP1 gene from your mother and one copy from your father.
What does my AZGP1 result mean for my family?
There is not yet a broadly confirmed inherited pattern linking AZGP1 to a specific genetic condition in families, though this can become clearer as research grows. If you have a specific AZGP1 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the AZGP1 gene, testing usually analyzes DNA from a blood sample or cheek swab. AZGP1 genetic testing reads the gene’s sequence and looks for changes that may help explain a confirmed diagnosis or clarify a lab finding.
When should I consider getting a genetic test?
There is not yet a broadly established reason to test the AZGP1 gene in routine care. Testing decisions are usually guided by your personal health and family history, together with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can be informative, but what it tells you varies depending on the condition and the type of variant present. Age, lifestyle, environment, and medical history are among the many factors that shape how the body functions over time. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people can take the same treatment, yet one may get better benefit while the other may notice less effect or more side effects. Part of the reason is that inherited differences can change how the body breaks down, moves, or responds to a drug. This kind of variation is common and helps explain why medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics is the area of medicine that looks at how genetic differences affect response to medications. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the AZGP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or changes in your health are best discussed with your doctor.
History
AZGP1 entered the medical literature in the 1960s, when researchers isolated a previously unknown protein from human blood and named it zinc alpha 2 glycoprotein. In the following decades, biochemical studies clarified its basic features, and later genetic work linked that protein to the AZGP1 gene. From these first observations, research expanded steadily. Interest grew further when AZGP1 was found in several body tissues and in some cancers, which led to studies on its value as a laboratory marker. More recent work has explored how AZGP1 expression changes in different health conditions, adding to its place in modern biomarker research.